Dual silencing of integrin αvβ3 receptor and insulin-like growth factor 1 receptor using mPEG-PCL/DDAB hybrid nanoparticle loaded siRNA in breast cancer therapy: An in vitro study on MCF-7 cells

This publication has 27 references indexed in Scilit:

• HULC targets the IGF1R–PI3K-AKT axis in trans to promote breast cancer metastasis and cisplatin resistance
  Cancer Letters, 2022
• siRNA-based nanocarriers for targeted drug delivery to control breast cancer
  Advances in Cancer Biology - Metastasis, 2022
• Co-delivery of siRNA and lycopene encapsulated hybrid lipid nanoparticles for dual silencing of insulin-like growth factor 1 receptor in MCF-7 breast cancer cell line
  International Journal of Biological Macromolecules, 2022
• Synthesis of methoxy poly(ethylene glycol)-poly(ε-caprolactone) diblock copolymers hybridized with DDAB cationic lipid as the efficient nanocarriers for in vitro delivery of lycopene into MCF-7 breast cancer cells
  Journal of Drug Delivery Science and Technology, 2021
• Novel lipid-polymer hybrid nanoparticles for siRNA delivery and IGF-1R gene silencing in breast cancer cells
  Journal of Drug Delivery Science and Technology, 2018
• Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R
  Food and Chemical Toxicology, 2018
• Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1
  Cytokine & Growth Factor Reviews, 2017
• Fabrication and functional attributes of lipidic nanoconstructs of lycopene: An innovative endeavour for enhanced cytotoxicity in MCF-7 breast cancer cells
  Colloids and Surfaces B: Biointerfaces, 2017
• PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives
  European Journal of Medicinal Chemistry, 2016
• siRNA Design Principles and Off-Target Effects
  2013